Latest news
Loading news…
Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.
Pionyr Immunotherapeutics was acquired by Ikena Oncology in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
43
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- South San Francisco, California, United States
Key People at Pionyr Immunotherapeutics
President and Chief Executive Officer
SVP of Technical Operations
CBO and SVP
43
professional contacts at Pionyr Immunotherapeutics
Contact execs at Pionyr Immunotherapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Pionyr Immunotherapeutics
Loading news…
FAQs about Pionyr Immunotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.